NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate compounds, today announced it has appointed James T. Gourzis, M.D., Ph.D., to its Board of Directors. Dr. Gourzis has provided clinical management and strategic development of the Company’s clinical trials.
